Riskpilot← Back to searchSign inGet full accessBitMED Aktiebolag
ABActiveOrg 5566197645Brädgårdsvägen 28Business and other management consultancy activities · NACE 7020Est. 20010 employees
Revenue 2025
SEK 1,7M
-5% vs 2024
EBITDA margin
19.1%
+314% vs 2024
Equity ratio
59.3%
Financial strength
Net profit 2025
SEK 251K
+661% vs 2024
| Revenue | SEK 1,7M | -5% |
| EBITDA | SEK 331K | +314% |
| Net profit | SEK 251K | +661% |
| Total assets | SEK 1,4M | -7% |
| Equity | SEK 851K | +0% |
| Employees | 0 | — |
Legal name
BitMED Aktiebolag
Org number
5566197645
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
17 december 2001
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall förvalta fast egendom, värdepapper och annan lös egendom. Bedriva affärsutveckling och konsultverksamhet inom områdena medicin, kläder, huvudbonader, vävnader, textil samt därtill närliggande produkter. Samt idka därmed förenlig verksamhet.
Address
Brädgårdsvägen 28
Phone
+46708453820
Email
marco.baroni@bitmedonline.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 307 | 3 062 | 2 029 | 1 817 | 1 729 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 117 | 1 448 | 118 | 80 | 331 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 117 | 1 448 | 118 | 80 | 331 |
| Net financials | −5 | 46 | −113 | −5 | −1 |
| Profit before tax | 113 | 1 106 | 80 | 75 | 331 |
| Tax | −33 | −240 | −51 | −42 | −80 |
| Net profit | 80 | 866 | 29 | 33 | 251 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 704 | 1 907 | 1 892 | 1 535 | 1 435 |
| Equity | 372 | 1 088 | 1 017 | 850 | 851 |
| Long-term debt | 110 | 0 | 0 | 0 | 0 |
| Short-term debt | 222 | 431 | 562 | 372 | 271 |
| Total debt | 332 | 431 | 562 | 372 | 271 |
EBITDA margin
19.1%
This company
15.8%
Market median
+21% vs market
20212025
Equity ratio
59.3%
This company
38.2%
Market median
+55% vs market
20212025
Return on equity
29.5%
This company
18.4%
Market median
+60% vs market
20212025
Net profit margin
14.5%
This company
8.1%
Market median
+79% vs market
20212025
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP | Audit | 2025 |
| Former (3) | ||
| Audit | 2022 – 2024 | |
LJ Auditor Substitute | Auditor Substitute | 2022 – 2024 |
SM Audit | Audit | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BitMED Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrika Ingeborg M Backenskiöld | Audit | 0 companies |
| Jonathan Peter Jason Yarnold | Audit | 0 companies |
| Lars Joakim Leifland | Auditor Substitute | 0 companies |
| Sven Mats Anderberg | Audit | 0 companies |
| Marco Peter Baroni | Board of Directors | 0 companies |
| David Emile Nyholm Baroni | Deputy Board Member | 0 companies |